Health CarePharmaceuticals & Biotechnology
  • Price (USD)165.37
  • Today's Change2.89 / 1.78%
  • Shares traded1.91m
  • 1 Year change32.73%
  • Beta0.7068
Data delayed at least 15 minutes, as of Sep 30 2020 21:10 BST.
More ▼
  • Health

    Dechra: pet theory

    FTSE 250 animal health group boosted by dealmaking and innovation

Key statistics

Zoetis Inc (ZTS:NYQ) set a new 52-week high during today's trading session when it reached 166.79. Over this period, the share price is up 35.23%.
52-week range
90.14Mar 23 2020166.79Sep 30 2020
Markit short selling activity
Previous close162.48
Average volume1.58m
Shares outstanding475.14m
Free float474.72m
P/E (TTM)48.06
Market cap77.20bn USD
EPS (TTM)3.38
Annual div (ADY)0.80
Annual div yield (ADY)0.49%
Div ex-dateJul 16 2020
Div pay-dateSep 01 2020
Data delayed at least 15 minutes, as of Sep 30 2020 21:10 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.